LFCR Lifecore Biomedical Inc
- Stocks
- Healthcare
- NASDAQ: LFCR
Price (delayed)
$6.77
Market cap
$253.25M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.27
Enterprise value
$371.99M
Relative Growth:
Rel. Growth:
20
Relative Strength:
Rel. Strength:
49
Relative Valuation:
Rel. Valuation:
22
Relative Profitability:
Rel. Profitability:
10
Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for
Highlights
The company's quick ratio has surged by 64% YoY and by 14% QoQ
LFCR's EPS is up by 15% QoQ
LFCR's equity has dropped by 88% year-on-year and by 40% since the previous quarter
Lifecore Biomedical's gross profit has decreased by 8% QoQ and by 3.7% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.landec.com
Key stats
What are the main financial stats of LFCR
Market
Valuations
Earnings
Shares outstanding
37.41M
Market cap
$253.25M
Enterprise value
$371.99M
Price to earnings (P/E)
N/A
Price to book (P/B)
187.62
Price to sales (P/S)
1.83
PEG
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.89
Revenue
$128.87M
Gross profit
$40.3M
Operating income
-$17.25M
Net income
-$38.72M
EBIT
-$16.84M
EBITDA
-$8.81M
Free cash flow
-$6.62M
Per share
Balance sheet
Liquidity
EPS
-$1.27
EPS diluted
-$1.27
Free cash flow per share
-$0.19
Book value per share
$0.04
Revenue per share
$3.7
TBVPS
$6.35
Total assets
$239.34M
Total liabilities
$191.91M
Debt
$127M
Equity
$1.34M
Working capital
$55.5M
Debt to equity
95.06
Current ratio
2.84
Quick ratio
1.49
Net debt/EBITDA
-13.47
Margins
Efficiency
Dividend
EBITDA margin
-6.8%
Gross margin
31.3%
Net margin
-30%
Operating margin
-13.4%
Return on assets
-18.1%
Return on equity
-1,176.9%
Return on invested capital
-5.3%
Return on capital employed
-8.1%
Return on sales
-13.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
LFCR stock price
How has the Lifecore Biomedical stock price performed over time
Intraday
-0.15%
1 week
-4.11%
1 month
-3.01%
1 year
10.35%
YTD
-8.88%
QTD
-8.02%
Financial performance
How have Lifecore Biomedical's revenue and profit performed over time
Revenue
$128.87M
Gross profit
$40.3M
Operating income
-$17.25M
Net income
-$38.72M
Gross margin
31.3%
Net margin
-30%
The company's operating income has shrunk by 95% YoY but it rose by 16% QoQ
LFCR's operating margin has plunged by 94% YoY but it is up by 15% from the previous quarter
Lifecore Biomedical's net margin has increased by 13% from the previous quarter
Lifecore Biomedical's net income has increased by 13% from the previous quarter
Price vs fundamentals
How does LFCR's price correlate with its fundamentals
Growth
What is Lifecore Biomedical's growth rate over time
Valuation
What is Lifecore Biomedical stock price valuation
P/E
N/A
P/B
187.62
P/S
1.83
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.89
LFCR's EPS is up by 15% QoQ
LFCR's equity has dropped by 88% year-on-year and by 40% since the previous quarter
The price to sales (P/S) is 27% lower than the 5-year quarterly average of 2.5 but 8% higher than the last 4 quarters average of 1.7
Efficiency
How efficient is Lifecore Biomedical business performance
LFCR's ROS has shrunk by 156% YoY but it is up by 24% QoQ
Lifecore Biomedical's return on invested capital has shrunk by 154% YoY but it has increased by 25% QoQ
Lifecore Biomedical's ROE has decreased by 49% from the previous quarter
The ROA has grown by 9% from the previous quarter
Dividends
What is LFCR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for LFCR.
Financial health
How did Lifecore Biomedical financials performed over time
LFCR's total assets is 25% more than its total liabilities
The company's quick ratio has surged by 64% YoY and by 14% QoQ
The company's current ratio rose by 37% YoY and by 4.8% QoQ
LFCR's equity has dropped by 88% year-on-year and by 40% since the previous quarter
The debt to equity has soared by 64% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.